Literature DB >> 23147937

Prostate cancer: challenges in selecting the optimal therapy.

Michael J Zelefsky.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23147937     DOI： 10.1038/nrurol.2012.193

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  3 in total

1.  Physician visits prior to treatment for clinically localized prostate cancer.

Authors:  Thomas L Jang; Justin E Bekelman; Yihai Liu; Peter B Bach; Ethan M Basch; Elena B Elkin; Michael J Zelefsky; Peter T Scardino; Colin B Begg; Deborah Schrag
Journal:  Arch Intern Med       Date:  2010-03-08

2.  Choice between prostatectomy and radiotherapy when men are eligible for both: a randomized controlled trial of usual care vs decision aid.

Authors:  Julia J van Tol-Geerdink; Jan Willem Leer; Philip C Weijerman; Inge M van Oort; Henk Vergunst; Emile N van Lin; J Alfred Witjes; Peep F Stalmeier
Journal:  BJU Int       Date:  2012-08-10       Impact factor: 5.588

3.  Secondary cancers after intensity-modulated radiotherapy, brachytherapy and radical prostatectomy for the treatment of prostate cancer: incidence and cause-specific survival outcomes according to the initial treatment intervention.

Authors:  Michael J Zelefsky; Xin Pei; Tatiana Teslova; Deborah Kuk; Juan Martin Magsanoc; Marisa Kollmeier; Brett Cox; Zhigang Zhang
Journal:  BJU Int       Date:  2012-08-13       Impact factor: 5.588
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.